NeuroSense Therapeutics Ltd. (NRSNW) Operating income 2021–2025
NeuroSense Therapeutics Ltd. (NRSNW) annual operating income history from SEC filings — each fiscal year as reported.
-$11.1MFY2025 · since FY2021: -$3.0M → -$11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.1M | -11.9% |
| FY2024 | -$9.9M | +17.8% |
| FY2023 | -$12.0M | -14.2% |
| FY2022 | -$10.6M | -253.6% |
| FY2021 | -$3.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice